(FibroGen Inc.)

	FGEN latest price $44.5000 (-5.62%) ($44.3000 - $48.4000) on Mon. Dec. 4, 2017.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.5% (three month average)
RSI	44
Latest Price	$44.5000(-5.62%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	FGEN declines -1.1% a day on average for past five trading days.
Weekly Trend	FGEN advances 0.5% a week on average for past two weeks.
Market Behavior	Rotation from growth to value for large cap. Rotation from growth to value for small cap.
Correlated ETFs	Broad market will support FGEN advance at 0% a week (0% probability)   XBI(35%)    IBB(28%)    IWO(27%)    VT(27%)    XLV(27%)
Factors Impacting FGEN price	FGEN will decline at least -1.25% in a week (0% probabilities).   UUP(-13%)    VIXM(-10%)    TLT(-7%)    UNG(-2%)    TIP(-1%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.25% (StdDev 2.5%)
Hourly BBV	0 ()
Intraday Trend	-6.3%

1 - 5 Day Possible Target	$35.97(-19.17%)
Resistance Level	$47.89
5 Day Moving Average	$46.68(-4.67%)
10 Day Moving Average	$47.04(-5.4%)
20 Day Moving Average	$47.89(-7.08%)
To recent high	-26%
To recent low	0%
Market Cap	$4.015b

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.

Analysis   News   Options   Weekly Chart   Daily Chart   2 Month Daily Chart   

  >  20180104